Submacular DL-α-aminoadipic acid eradicates primate photoreceptors but does not affect luteal pigment or the retinal vasculature

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 1, 2011, Pages 119-127

  Shen, weiyong ^a   Zhang, jun ^b   Chung, Sook Hyun ^a   Hu, yuntao ^b   Ma, zhizhong ^b   Gillies, Mark C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRO 2 AMINOADIPIC ACID; LUTEA PIGMENT; UNCLASSIFIED DRUG; VISUAL PIGMENT; 2 AMINOADIPIC ACID; AMINO ACID RECEPTOR BLOCKING AGENT; XANTHOPHYLL; ZEAXANTHIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOFLUORESCENCE IMAGING; BLOOD RETINA BARRIER; CELL DISRUPTION; CELL LOSS; CELL VIABILITY; CONTROLLED STUDY; ELECTRORETINOGRAPHY; EYE PHOTOGRAPHY; FLUORESCENCE ANGIOGRAPHY; GLIA CELL; HAPLORHINI; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MUELLER CELL; MULTIFOCAL ELECTRORETINOGRAPHY; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; PATHOGENESIS; PHOTORECEPTOR CELL; PRIORITY JOURNAL; PROTEIN DEPLETION; RETINA BLOOD VESSEL; RETINA FOVEA; RETINA MACULA TELANGIECTASIA TYPE 2; RETINAL TELANGIECTASIA; ANIMAL; CELL CULTURE; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECT; MACACA; METABOLISM; NERVE FIBER; PATHOLOGY; PHOTOGRAPHY; PHYSIOLOGY; RETINA CONE; RETINA GANGLION CELL; RETINA NERVE CELL;

2-AMINOADIPIC ACID; ANIMALS; BLOOD-RETINAL BARRIER; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRORETINOGRAPHY; EXCITATORY AMINO ACID ANTAGONISTS; FLUORESCEIN ANGIOGRAPHY; LUTEIN; MACACA; NERVE FIBERS; PHOTOGRAPHY; PHOTORECEPTOR CELLS, VERTEBRATE; RETINAL CONE PHOTORECEPTOR CELLS; RETINAL GANGLION CELLS; RETINAL NEURONS; RETINAL VESSELS; TOMOGRAPHY, OPTICAL COHERENCE; XANTHOPHYLLS;

EID: 79952227183     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-6033     Document Type: Article

References (50)

1. Issa PC, Berendschot TT, Staurenghi G, Holz FG, Scholl HP. Confocal blue reflectance imaging in type 2 idiopathic macular telangiectasia. Invest Ophthalmol Vis Sci. 2008;49:1172-1177.
2. Issa PC, van der Veen RL, Stijfs A, Holz FG, Scholl HP, Berendschot TT. Quantification of reduced macular pigment optical density in the central retina in macular telangiectasia type 2. Exp Eye Res. 2009;89:25-31.
3. Helb HM, Issa PC, van der Veen RL, Berendschot TT, Scholl HP, Holz FG. Abnormal macular pigment distribution in type 2 idiopathic macular telangiectasia. Retina. 2008;28:808-816.
4. Yannuzzi LA, Bardal AM, Freund KB, Chen KJ, Eandi CM, Blodi B. Idiopathic macular telangiectasia. Arch Ophthalmol. 2006;124: 450-460.
5. Wong WT, Forooghian F, Majumdar Z, Bonner RF, Cunningham D, Chew EY. Fundus autofluorescence in type 2 idiopathic macular telangiectasia: correlation with optical coherence tomography and microperimetry. Am J Ophthalmol. 2009;148:573-583.
6. Abujamra S, Bonanomi MT, Cresta FB, Machado CG, Pimentel SL, Caramelli CB. Idiopathic juxtafoveolar retinal telangiectasis: clinical pattern in 19 cases. Ophthalmologica. 2000;214:406-411.
7. Paunescu LA, Ko TH, Duker JS, et al. Idiopathic juxtafoveal retinal telangiectasis: new findings by ultrahigh-resolution optical coherence tomography. Ophthalmology. 2006;113:48-57.
8. Tikellis G, Gillies MC, Guymer RH, McAllister IL, Shaw JE, Wong TY. Retinal vascular caliber and macular telangiectasia type 2. Ophthalmology. 2009;116:319-323.
9. Barthelmes D, Gillies MC, Sutter FK. Quantitative OCT analysis of idiopathic perifoveal telangiectasia. Invest Ophthalmol Vis Sci. 2008;49:2156-2162.
10. Issa PC, Helb HM, Holz FG, Scholl HP. Correlation of macular function with retinal thickness in nonproliferative type 2 idiopathic macular telangiectasia. Am J Ophthalmol. 2008;145: 169-175.
11. Issa P.C, Helb HM, Rohrschneider K, Holz FG, Scholl HP. Microperimetric assessment of patients with type 2 idiopathic macular telangiectasia. Invest Ophthalmol Vis Sci. 2007;48:3788-3795.
12. Issa P.C, Holz FG, Scholl HP. Findings in fluorescein angiog-raphy and optical coherence tomography after intravitreal bevaci-zumab in type 2 idiopathic macular telangiectasia. Ophthalmology. 2007;114:1736-1742.
13. Issa PC, Finger RP, Helb HM, Holz FG, Scholl HP. A new diagnostic approach in patients with type 2 macular telangiectasia: confocal reflectance imaging. Acta Ophthalmol. 2008;86:464-465.
14. Issa PC, Finger RP, Holz FG, Scholl HP. Eighteen-month follow-up of intravitreal bevacizumab in type 2 idiopathic macular telangiectasia. Br J Ophthalmol. 2008;92:941-945.
15. Maruko I, Iida T, Sekiryu T, Fujiwara T. Early morphological changes and functional abnormalities in group 2A idiopathic jux-tafoveolar retinal telangiectasis using spectral domain optical coherence tomography and microperimetry. Br J Ophthalmol. 2008; 92:1488-1491.
16. Surguch V, Gamulescu MA, Gabel VP. Optical coherence tomography findings in idiopathic juxtafoveal retinal telangiectasis. Graefes Arch Clin Exp Ophthalmol. 2007;245:783-788.
17. Zeimer MB, Padge B, Heimes B, Pauleikhoff D. Idiopathic macular telangiectasia type 2: distribution of macular pigment and functional investigations. Retina. 30:586-595.
18. Davies NP, Morland AB. Macular pigments: their characteristics and putative role. Prog Retin Eye Res. 2004;23:533-559.
19. Trieschmann M, van Kuijk FJ, Alexander R, et al. Macular pigment in the human retina: histological evaluation of localization and distribution. Eye (Lond). 2008;22:132-137.
20. Whitehead AJ, Mares JA, Danis RP. Macular pigment: a review of current knowledge. Arch Ophthalmol. 2006;124:1038-1045.
21. Gass JD. Muller cell cone, an overlooked part of the anatomy of the fovea centralis: hypotheses concerning its role in the pathogenesis of macular hole and foveomacular retinoschisis. Arch Ophthalmol. 1999;117:821-823.
22. Yamada E. Some structural features of the fovea centralis in the human retina. Arch Ophthalmol. 1969;82:151-159.
23. Bringmann A, Pannicke T, Grosche J, et al. Muller cells in the healthy and diseased retina. Prog Retin Eye Res. 2006;25:397-424.
24. Reichenbach A, Wurm A, Pannicke T, Iandiev I, Wiedemann P, Bringmann A. Muller cells as players in retinal degeneration and edema. Graefes Arch Clin Exp Ophthalmol. 2007;245:627-636.
25. Dyer MA, Cepko CL. Control of Muller glial cell proliferation and activation following retinal injury. Nat Neurosci. 2000;3:873-880.
26. Kato S, Ishita S, Sugawara K, Mawatari K. Cystine/glutamate anti-porter expression in retinal Muller glial cells: implications for DL-αlpha-aminoadipate toxicity. Neuroscience. 1993;57:473-482.
27. Kato S, Sugawara K, Matsukawa T, Negishi K. Gliotoxic effects of alpha-aminoadipic acid isomers on the carp retina: a long term observation. Neuroscience. 1990;36:145-153.
28. Zimmerman RP, Corfman TP. A comparison of the effects of isomers of alpha-aminoadipic acid and 2-amino-4-phosphonobu-tyric acid on the light response of the Muller glial cell and the electroretinogram. Neuroscience. 1984;12:77-84.
29. Linser PJ, Moscona AA. Induction of glutamine synthetase in embryonic neural retina: its suppression by the gliatoxic agent alpha-aminoadipic acid. Brain Res. 1981;227:103-119.
30. Pow DV. Visualising the activity of the cystine-glutamate antiporter in glial cells using antibodies to aminoadipic acid, a selectively transported substrate. Glia. 2001;34:27-38.
31. Shen W, Li S, Chung SH, Gillies MC. Retinal vascular changes after glial disruption in rats. J Neurosci Res. 2010;88:1485-1499.
32. Hendrickson AE. Primate foveal development: a microcosm of current questions in neurobiology. Invest Ophthalmol Vis Sci. 1994;35:3129-3133.
33. LaVail MM. Photoreceptor characteristics in congenic strains of RCS rats. Invest Ophthalmol Vis Sci. 1981;20:671-675.
34. Lai CM, Shen WY, Brankov M, et al. Long-term evaluation of AAV-mediated sFlt-1 gene therapy for ocular neovascularization in mice and monkeys. Mol Ther. 2005;12:659-668.
35. Hood DC, Bach M, Brigell M, et al. ISCEV guidelines for clinical multifocal electroretinography (2007 edition). Doc Ophthalmol. 2008;116:1-11.
36. Shen WY, Garrett KL, Wang CG, et al. Preclinical evaluation of a phosphorothioate oligonucleotide in the retina of rhesus monkey. Lab Invest. 2002;82:167-182.
37. Tan E, Ding XQ, Saadi A, Agarwal N, Naash MI, Al-Ubaidi MR. Expression of cone-photoreceptor-specific antigens in a cell line derived from retinal tumors in transgenic mice. Invest Ophthalmol Vis Sci. 2004;45:764-768.
38. Landrum JT, Bone RA. Lutein, zeaxanthin, and the macular pigment. Arch Biochem Biophys. 2001;385:28-40.
39. Koizumi H, Slakter JS, Spaide RF. Full-thickness macular hole formation in idiopathic parafoveal telangiectasis. Retina. 2007;27: 473-476.
40. Bhosale P, Larson AJ, Frederick JM, Southwick K, Thulin CD, Bernstein PS. Identification and characterization of a Pi isoform of glutathione S-transferase (GSTP1) as a zeaxanthin-binding protein in the macula of the human eye. J Biol Chem. 2004;279:49447-49454.
41. Bhosale P, Li B, Sharifzadeh M, et al. Purification and partial characterization of a lutein-binding protein from human retina. Biochemistry. 2009;48:4798-4807.
42. Cantarella G, Lempereur L, Presta M, et al. Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo. FASEB J. 2002;16:1307-1309.
43. Carmeliet P, Tessier-Lavigne M. Common mechanisms of nerve and blood vessel wiring. Nature. 2005;436:193-200.
44. Liu X, Li Y, Liu Y, et al. Endothelial progenitor cells (EPCs) mobilized and activated by neurotrophic factors may contribute to pathologic neovascularization in diabetic retinopathy. Am J Pathol. 176:504-515.
45. Suchting S, Bicknell R, Eichmann A. Neuronal clues to vascular guidance. Exp Cell Res. 2006;312:668-675.
46. Barthelmes D, Gillies MC, Fleischhauer JC, Sutter FK. A case of idiopathic perifoveal telangiectasia preceded by features of cone dystrophy. Eye (Lond). 2007;21:1534-1535.
47. Greenberg KP, Geller SF, Schaffer DV, Flannery JG. Targeted trans-gene expression in Muller glia of normal and diseased retinas using lentiviral vectors. Invest Ophthalmol Vis Sci. 2007;48:1844-1852.
48. Miyoshi H, Takahashi M, Gage FH, Verma IM. Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc Natl Acad Sci USA. 1997;94:10319-10323.
49. Vazquez-Chona FR, Clark AM, Levine EM. Rlbp1 promoter drives robust Muller glial GFP expression in transgenic mice. Invest Ophthalmol Vis Sci. 2009;50:3996-4003.
50. Wu S, Wu Y, Capecchi MR. Motoneurons and oligodendrocytes are sequentially generated from neural stem cells but do not appear to share common lineage-restricted progenitors in vivo. Development. 2006;133:581-590.